1st Quarter - Report
HAGGERTY POLICY SOLUTIONS for AMGEN
Client
Income
$22,500
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
FDA Prescription Drug User Fee Reauthorization (not yet introduced) - accelerated approval issues, user fee agreements
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEANNE HAGGERTY | — |
Medicare/Medicaid MMM
H.R. 5376 - Build Back Better Act - drug pricing provisions S. 1943, Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEANNE HAGGERTY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.